Virologic outcomes on dolutegravir-, atazanavir-, or efavirenz-based ART in urban Zimbabwe: A longitudinal study. Shamu T, Egger M, Mudzviti T, Chimbetete C, et al. PLoS One 2024;19:e0293162.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shamu T, Egger M, Mudzviti T, Chimbetete C, et al. Virologic outcomes on dolutegravir-, atazanavir-, or efavirenz-based ART in urban Zimbabwe: A longitudinal study. PLoS One 2024;19:e0293162.
PMID: 38394297